Published in Ann Rheum Dis on August 11, 2012
Pneumococcal polysaccharide vaccination in rheumatoid arthritis patients receiving tocilizumab therapy. Ann Rheum Dis (2013) 0.93
The effect of tofacitinib on pneumococcal and influenza vaccine responses in rheumatoid arthritis. Ann Rheum Dis (2015) 0.86
[Vaccination in adult patients with chronic inflammatory rheumatic diseases]. Z Rheumatol (2013) 0.84
Humoral immune response to vaccines in patients with rheumatoid arthritis treated with tocilizumab: results of a randomised controlled trial (VISARA). Ann Rheum Dis (2014) 0.84
Effects of biological and non-biological immunomodulatory therapies on the immunogenicity of vaccines in patients with rheumatic diseases. Arthritis Res Ther (2014) 0.83
Rituximab and abatacept but not tocilizumab impair antibody response to pneumococcal conjugate vaccine in patients with rheumatoid arthritis. Arthritis Res Ther (2013) 0.81
Vaccinations for rheumatoid arthritis. Curr Rheumatol Rep (2014) 0.78
Investigation of clinical characteristics as predictive factors for the humoral immune response to the influenza vaccine in patients with rheumatoid arthritis. Clin Rheumatol (2014) 0.76
Impact of anti-rheumatic treatment on immunogenicity of pandemic H1N1 influenza vaccine in patients with arthritis. Arthritis Res Ther (2014) 0.76
The role of IL-6 in host defence against infections: immunobiology and clinical implications. Nat Rev Rheumatol (2017) 0.75
A literature review on the patients with autoimmune diseases following vaccination against infections. Hum Vaccin Immunother (2015) 0.75
[Guidelines for vaccination of immunocompromised individuals]. Wien Klin Wochenschr (2016) 0.75
Impaired immune and acute-phase responses in interleukin-6-deficient mice. Nature (1994) 8.85
Double-blind randomized controlled clinical trial of the interleukin-6 receptor antagonist, tocilizumab, in European patients with rheumatoid arthritis who had an incomplete response to methotrexate. Arthritis Rheum (2006) 5.20
Frequency of infection in patients with rheumatoid arthritis compared with controls: a population-based study. Arthritis Rheum (2002) 4.69
The essential role of B cell stimulatory factor 2 (BSF-2/IL-6) for the terminal differentiation of B cells. J Exp Med (1988) 4.31
Study of active controlled monotherapy used for rheumatoid arthritis, an IL-6 inhibitor (SAMURAI): evidence of clinical and radiographic benefit from an x ray reader-blinded randomised controlled trial of tocilizumab. Ann Rheum Dis (2007) 4.05
Recent insights in the pharmacological actions of methotrexate in the treatment of rheumatoid arthritis. Rheumatology (Oxford) (2007) 1.78
Specific antibody response after influenza immunization in systemic lupus erythematosus. J Rheumatol (2002) 1.77
Impact of synthetic and biologic disease-modifying antirheumatic drugs on antibody responses to the AS03-adjuvanted pandemic influenza vaccine: a prospective, open-label, parallel-cohort, single-center study. Arthritis Rheum (2011) 1.67
Vaccination against influenza in rheumatoid arthritis: the effect of disease modifying drugs, including TNF alpha blockers. Ann Rheum Dis (2005) 1.59
Anti-tumor necrosis factor therapy does not diminish the immune response to influenza vaccine in Japanese patients with rheumatoid arthritis. Mod Rheumatol (2007) 1.52
Immune responses following administration of influenza and pneumococcal vaccines to patients with rheumatoid arthritis receiving adalimumab. J Rheumatol (2007) 1.41
Influenza vaccination as model for testing immune modulation induced by anti-TNF and methotrexate therapy in rheumatoid arthritis patients. Rheumatology (Oxford) (2006) 1.40
Interleukin-6 inhibition for treatment of rheumatoid arthritis: a review of tocilizumab therapy. Drug Des Devel Ther (2010) 1.38
The effect of anti-tumour necrosis factor alpha treatment on the antibody response to influenza vaccination. Ann Rheum Dis (2007) 1.34
Influenza vaccine administration in rheumatoid arthritis patients under treatment with TNFalpha blockers: safety and immunogenicity. Clin Immunol (2009) 1.04
Tocilizumab, a humanized anti-interleukin-6 receptor antibody, ameliorates joint swelling in established monkey collagen-induced arthritis. Biol Pharm Bull (2008) 0.99
Safety and response to influenza vaccine in patients with systemic-onset juvenile idiopathic arthritis receiving tocilizumab. Mod Rheumatol (2012) 0.98
The effect of infliximab and timing of vaccination on the humoral response to influenza vaccination in patients with rheumatoid arthritis and ankylosing spondylitis. Semin Arthritis Rheum (2009) 0.92
Interleukin 6 is not required for antigen-specific antibody responses by human B cells. Eur J Immunol (1993) 0.87
The first identification and retrospective study of Severe Fever with Thrombocytopenia Syndrome in Japan. J Infect Dis (2013) 4.92
Characteristics of a large cohort of patients with autoimmune pulmonary alveolar proteinosis in Japan. Am J Respir Crit Care Med (2008) 2.29
Comparison of clinical features and hematologic abnormalities between dengue fever and dengue hemorrhagic fever among children in the Philippines. Am J Trop Med Hyg (2005) 1.45
A clinical, serological, and immunological study in a Japanese traveler with dengue fever. J Infect Chemother (2002) 1.40
Essential contribution of monocyte chemoattractant protein-1/C-C chemokine ligand-2 to resolution and repair processes in acute bacterial pneumonia. J Immunol (2004) 1.35
Sepsis and spontaneous bacterial peritonitis in Thailand. Lancet (2011) 1.33
Effects of the anti-interleukin-6 receptor antibody, tocilizumab, on serum lipid levels in patients with rheumatoid arthritis. Rheumatol Int (2009) 1.27
Comparison of antibiotic resistance and serotype composition of carriage and invasive pneumococci among Bangladeshi children: implications for treatment policy and vaccine formulation. J Clin Microbiol (2003) 1.24
Genotypic profile of Streptococcus suis serotype 2 and clinical features of infection in humans, Thailand. Emerg Infect Dis (2011) 1.23
Fatal sepsis caused by an unusual Klebsiella species that was misidentified by an automated identification system. J Med Microbiol (2013) 1.22
Pneumocystis jirovecii infection: an emerging threat to patients with rheumatoid arthritis. Rheumatology (Oxford) (2012) 1.21
Phase III study of the efficacy and safety of subcutaneous versus intravenous tocilizumab monotherapy in patients with rheumatoid arthritis. Arthritis Care Res (Hoboken) (2014) 1.10
Clonal dissemination of human isolates of Streptococcus suis serotype 14 in Thailand. J Med Microbiol (2009) 1.09
Continuation of methotrexate resulted in better clinical and radiographic outcomes than discontinuation upon starting etanercept in patients with rheumatoid arthritis: 52-week results from the JESMR study. J Rheumatol (2011) 1.06
Correlation between common carotid arterial wall thickness and ischemic stroke in patients with type 2 diabetes mellitus. Metabolism (2002) 1.05
Evaluation of a dengue IgG indirect enzyme-linked immunosorbent assay and a Japanese encephalitis IgG indirect enzyme-linked immunosorbent assay for diagnosis of secondary dengue virus infection. Vector Borne Zoonotic Dis (2010) 1.02
Population-based study of Streptococcus suis infection in humans in Phayao Province in northern Thailand. PLoS One (2012) 1.01
Drug free REmission/low disease activity after cessation of tocilizumab (Actemra) Monotherapy (DREAM) study. Mod Rheumatol (2014) 1.01
Platelet apoptosis and apoptotic platelet clearance by macrophages in secondary dengue virus infections. J Infect Dis (2012) 1.01
The contribution of suilysin to the pathogenesis of Streptococcus suis meningitis. J Infect Dis (2013) 1.00
Different risk factors between interstitial lung disease and airway disease in rheumatoid arthritis. Respir Med (2012) 1.00
Time-dependent increased risk for serious infection from continuous use of tumor necrosis factor antagonists over three years in patients with rheumatoid arthritis. Arthritis Care Res (Hoboken) (2012) 1.00
Secretory-IgA antibodies play an important role in the immunity to Streptococcus pneumoniae. J Immunol (2010) 0.99
Emergence of rifampin-resistant Rhodococcus equi with several types of mutations in the rpoB gene among AIDS patients in northern Thailand. J Clin Microbiol (2003) 0.99
Increased phagocytosis of platelets from patients with secondary dengue virus infection by human macrophages. Am J Trop Med Hyg (2009) 0.99
Lack of efficacy of high-dose intravenous immunoglobulin treatment of severe thrombocytopenia in patients with secondary dengue virus infection. Am J Trop Med Hyg (2007) 0.99
Decreased serum opsonic activity against Streptococcus pneumoniae in human immunodeficiency virus-infected Ugandan adults. Clin Infect Dis (2003) 0.97
Churg-strauss syndrome with cholecystitis and renal involvement. Intern Med (2003) 0.97
High serum concentrations of soluble E-selectin correlate with obesity but not fat distribution in patients with type 2 diabetes mellitus. Metabolism (2002) 0.96
Novel bat-borne hantavirus, Vietnam. Emerg Infect Dis (2013) 0.95
High rate of transmission of penicillin-resistant Streptococcus pneumoniae between parents and children. J Clin Microbiol (2002) 0.95
Etanercept (ETN) with methotrexate (MTX) is better than ETN monotherapy in patients with active rheumatoid arthritis despite MTX therapy: a randomized trial. Mod Rheumatol (2010) 0.94
Pneumococcal polysaccharide vaccination in rheumatoid arthritis patients receiving tocilizumab therapy. Ann Rheum Dis (2013) 0.93
Fifteen Streptococcus suis serotypes identified by multiplex PCR. J Med Microbiol (2012) 0.93
Possible high rate of transmission of nontypeable Haemophilus influenzae, including beta-lactamase-negative ampicillin-resistant strains, between children and their parents. J Clin Microbiol (2004) 0.93
CD4-independent human immunodeficiency virus infection involves participation of endocytosis and cathepsin B. PLoS One (2011) 0.93
Serum concentrations of soluble adhesion molecules are related to degree of hyperglycemia and insulin resistance in patients with type 2 diabetes mellitus. Diabetes Res Clin Pract (2002) 0.93
Latest developments on Streptococcus suis: an emerging zoonotic pathogen: part 1. Future Microbiol (2014) 0.92
Drug retention rates and relevant risk factors for drug discontinuation due to adverse events in rheumatoid arthritis patients receiving anticytokine therapy with different target molecules. Ann Rheum Dis (2012) 0.92
Increased rates of intense nasopharyngeal bacterial colonization of Vietnamese children with radiological pneumonia. Tohoku J Exp Med (2007) 0.92
Additive effect of pneumococcal vaccine and influenza vaccine on acute exacerbation in patients with chronic lung disease. Vaccine (2008) 0.92
Genetic analysis of non-hydrogen sulfide-producing Salmonella enterica serovar typhimurium and S. enterica serovar infantis isolates in Japan. J Clin Microbiol (2012) 0.92
Evaluation of estimated number of influenza patients from national sentinel surveillance using the national database of electronic medical claims. Jpn J Infect Dis (2014) 0.92
Identification of a host gene subset related to disease prognosis of HIV-1 infected individuals. Int Immunopharmacol (2004) 0.92
Impact of pandemic influenza (H1N1) virus-associated community-acquired pneumonia among adults in a tertiary hospital in Thailand. Jpn J Infect Dis (2010) 0.92
Fourteen-member macrolides promote the phosphatidylserine receptor-dependent phagocytosis of apoptotic neutrophils by alveolar macrophages. Antimicrob Agents Chemother (2003) 0.92
Genetic analysis of attachment glycoprotein (G) gene in new genotype ON1 of human respiratory syncytial virus detected in Japan. Microbiol Immunol (2013) 0.91
Inflammation and insulin resistance are independently related to all-cause of death and cardiovascular events in Japanese patients with type 2 diabetes mellitus. Atherosclerosis (2003) 0.91
Recurrent bacterial meningitis by three different pathogens in an isolated asplenic child. J Infect Chemother (2011) 0.89
Leukocytapheresis (LCAP) decreases the level of platelet-derived microparticles (MPs) and increases the level of granulocytes-derived MPs: a possible connection with the effect of LCAP on rheumatoid arthritis. Mod Rheumatol (2009) 0.89
Latest developments on Streptococcus suis: an emerging zoonotic pathogen: part 2. Future Microbiol (2014) 0.89
Intranasal immunization with a mixture of PspA and a Toll-like receptor agonist induces specific antibodies and enhances bacterial clearance in the airways of mice. Vaccine (2009) 0.89
Epidemiological and clinical features of idiopathic pulmonary alveolar proteinosis in Japan. Respirology (2006) 0.89
Radiological features and therapeutic responses of pulmonary nontuberculous mycobacterial disease in rheumatoid arthritis patients receiving biological agents: a retrospective multicenter study in Japan. Mod Rheumatol (2011) 0.88
The nasal dendritic cell-targeting Flt3 ligand as a safe adjuvant elicits effective protection against fatal pneumococcal pneumonia. Infect Immun (2011) 0.88
Cytokine production and signaling pathways in respiratory virus infection. Front Microbiol (2013) 0.88
Molecular evolution of attachment glycoprotein (G) gene in human respiratory syncytial virus detected in Japan 2008-2011. Infect Genet Evol (2013) 0.88
In rheumatoid arthritis patients treated with tocilizumab, the rate of clinical disease activity index (CDAI) remission at 24 weeks is superior in those with higher titers of IgM-rheumatoid factor at baseline. Mod Rheumatol (2011) 0.87
Invasive Haemophilus influenzae type B diseases in Bangladesh, with increased resistance to antibiotics. J Pediatr (2005) 0.87
Effectiveness of pneumococcal polysaccharide vaccine against pneumonia and cost analysis for the elderly who receive seasonal influenza vaccine in Japan. Vaccine (2010) 0.86
Clinical manifestations of coxsackievirus A6 infection associated with a major outbreak of hand, foot, and mouth disease in Japan. Jpn J Infect Dis (2013) 0.86
Prediction of DAS28-ESR remission at 6 months by baseline variables in patients with rheumatoid arthritis treated with etanercept in Japanese population. Mod Rheumatol (2009) 0.86
[A case of community-acquired pneumonia caused by Corynebacterium propinquum]. Kansenshogaku Zasshi (2003) 0.86
Low opsonic activity to the infecting serotype in pediatric patients with invasive pneumococcal disease. Vaccine (2012) 0.85
Identification and characterization of a type III secretion-associated chaperone in the type III secretion system 1 of Vibrio parahaemolyticus. FEMS Microbiol Lett (2009) 0.85
[Three adult cases with Corynebacterium propinquum respiratory infections in a community hospital]. Kansenshogaku Zasshi (2004) 0.85
Complex regional pain syndrome type I induced by pacemaker implantation, with a good response to steroids and neurotropin. Intern Med (2002) 0.84
Nitric oxide acts on the mitochondria and protects human endothelial cells from apoptosis. J Lab Clin Med (2004) 0.84
Induction of opsonophagocytic killing activity with pneumococcal conjugate vaccine in human immunodeficiency virus-infected Ugandan adults. Vaccine (2008) 0.83
Intranasal vaccination with pneumococcal surface protein A plus poly(I:C) protects against secondary pneumococcal pneumonia in mice. Vaccine (2011) 0.83
Influence of coffee (Coffea arabica) and galacto-oligosaccharide consumption on intestinal microbiota and the host responses. FEMS Microbiol Lett (2013) 0.83
Possible relationship of PFGE patterns of Moraxella catarrhalis between hospital- and community-acquired respiratory infections in a community hospital. Microbiol Immunol (2003) 0.83
Acid aspiration induces bacterial pneumonia by enhanced bacterial adherence in mice. Microb Pathog (2002) 0.82
Cathepsin L is required for ecotropic murine leukemia virus infection in NIH3T3 cells. Virology (2009) 0.82
Immune complexome analysis of serum and its application in screening for immune complex antigens in rheumatoid arthritis. Clin Chem (2011) 0.81
Novel mutations in TNFRSF1A in patients with typical tumor necrosis factor receptor-associated periodic syndrome and with systemic lupus erythematosus in Japanese. Int J Mol Med (2004) 0.81
Polyarteritis associated with hypopharyngeal carcinoma. Intern Med (2002) 0.81
Identification of the Vibrio parahaemolyticus type III secretion system 2-associated chaperone VocC for the T3SS2-specific effector VopC. FEMS Microbiol Lett (2011) 0.81
Fourteen-member macrolides suppress interleukin-8 production but do not promote apoptosis of activated neutrophils. Antimicrob Agents Chemother (2002) 0.81
Antimicrobial susceptibility and serotype distribution of Streptococcus pneumoniae and molecular characterization of multidrug-resistant serotype 19F, 6B, and 23F Pneumococci in northern Thailand. J Clin Microbiol (2003) 0.81
Comparative immune responses of patients with chronic pulmonary diseases during the 2-year period after pneumococcal vaccination. Clin Vaccine Immunol (2006) 0.81
Efficacy and safety of mizoribine by one single dose administration for patients with rheumatoid arthritis. Intern Med (2010) 0.81
Decrement of serum cartilage oligomeric matrix protein (COMP) in rheumatoid arthritis (RA) patients achieving remission after 6 months of etanercept treatment: comparison with CRP, IgM-RF, MMP-3 and anti-CCP Ab. Joint Bone Spine (2010) 0.80
Enhanced effect of high-dose leukocytapheresis using a large filter in rheumatoid arthritis. Mod Rheumatol (2007) 0.80
A multicenter phase II study of carboplatin and paclitaxel with a biweekly schedule in patients with advanced non-small-cell lung cancer: Kyushu thoracic oncology group trial. Cancer Chemother Pharmacol (2006) 0.80
Methotrexate chronotherapy is effective against rheumatoid arthritis. Chronobiol Int (2011) 0.80
Graves' hyperthyroidism and the hygiene hypothesis in a mouse model. Endocrinology (2004) 0.80
Outbreak of Streptococcus pneumoniae serotype 3 pneumonia in extremely elderly people in a nursing home unit in Kanagawa, Japan, 2013. J Am Geriatr Soc (2014) 0.80
Reduction in serum levels of substance P in patients with rheumatoid arthritis by etanercept, a tumor necrosis factor inhibitor. Mod Rheumatol (2010) 0.80
Prediction of DAS28-CRP remission in patients with rheumatoid arthritis treated with tacrolimus at 6 months by baseline variables. Mod Rheumatol (2009) 0.80
Soluble adhesion molecule E-selectin predicts cardiovascular events in Japanese patients with type 2 diabetes mellitus. Metabolism (2009) 0.80
Prognostic Factors Toward Clinically Relevant Radiographic Progression in Patients With Rheumatoid Arthritis in Clinical Practice: A Japanese Multicenter, Prospective Longitudinal Cohort Study for Achieving a Treat-to-Target Strategy. Medicine (Baltimore) (2016) 0.79